Leucine
- Generic Name
- Leucine
- Brand Names
- Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %
- Drug Type
- Small Molecule
- Chemical Formula
- C6H13NO2
- CAS Number
- 61-90-5
- Unique Ingredient Identifier
- GMW67QNF9C
- Background
An essential branched-chain amino acid important for hemoglobin formation.
- Indication
Indicated to assist in the prevention of the breakdown of muscle proteins that sometimes occur after trauma or severe stress.
- Associated Conditions
- Hypoalbuminemia
- Associated Therapies
- Amino acid supplementation
COMT Polymorphism and Entacapone Efficacy
Phase 4
Completed
- Conditions
- Parkinson's Disease
- Interventions
- First Posted Date
- 2006-09-07
- Last Posted Date
- 2010-04-29
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 60
- Registration Number
- NCT00373087
- Locations
- 🇫🇷
Centre d'Investigation Clinique, Hôpital de la Pitié-Salpétrière,, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath